Cardiac biomarkers and clinical scores for risk stratification in elderly patients with non-high-risk pulmonary embolism.

Vuilleumier, N; Limacher, A; Méan, M; Choffat, J; Lescuyer, P; Bounameaux, H; Aujesky, D; Righini, M (2015). Cardiac biomarkers and clinical scores for risk stratification in elderly patients with non-high-risk pulmonary embolism. Journal of internal medicine, 277(6), pp. 707-716. Blackwell Scientific Publications 10.1111/joim.12316

Text Vuilleumier JInternMed 2015.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (154kB)

OBJECTIVE

To determine the prognostic accuracy of cardiac biomarkers alone and in combination with clinical scores in elderly patients with non-high-risk pulmonary embolism (PE).

DESIGN

Ancillary analysis of a Swiss multicentre prospective cohort study.

SUBJECTS

A total of 230 patients aged ≥65 years with non-high-risk PE.

MAIN OUTCOME MEASURES

The study end-point was a composite of PE-related complications, defined as PE-related death, recurrent venous thromboembolism or major bleeding during a follow-up of 30 days. The prognostic accuracy of the Pulmonary Embolism Severity Index (PESI), the Geneva Prognostic Score (GPS), the precursor of brain natriuretic peptide (NT-proBNP) and high-sensitivity cardiac troponin T (hs-cTnT) was determined using sensitivity, specificity, predictive values, receiver operating characteristic (ROC) curve analysis, logistic regression and reclassification statistics.

RESULTS

The overall complication rate during follow-up was 8.7%. hs-cTnT achieved the highest prognostic accuracy [area under the ROC curve: 0.75, 95% confidence interval (CI): 0.63-0.86, P < 0.001). At the predefined cut-off values, the negative predictive values of the biomarkers were above 95%. For levels above the cut-off, the risk of complications increased fivefold for hs-cTnT [odds ratio (OR): 5.22, 95% CI: 1.49-18.25] and 14-fold for NT-proBNP (OR: 14.21, 95% CI: 1.73-116.93) after adjustment for both clinical scores and renal function. Reclassification statistics indicated that adding hs-cTnT to the GPS or the PESI significantly improved the prognostic accuracy of both clinical scores.

CONCLUSION

In elderly patients with nonmassive PE, NT-proBNP or hs-cTnT could be an adequate alternative to clinical scores for identifying low-risk individuals suitable for outpatient management.

Interest & Impact

Downloads

3 since deposited on 03 Feb 2015
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item